Integra LifeSciences Holdings Corporation announced that Jan De Witte intention to retire from his position as President and director of the Company following the completion of a succession process. To ensure a smooth transition, Mr. De Witte will remain at the Company and continue to serve as President and Chief Executive Officer and as a Board member until the effective date of the Board?s appointment of his successor. Mr. DeWitte?s plans to retire are for personal reasons and not because of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.

On February 27, 2024, the Company?s Board of Directors appointed Stuart M. Essig, Ph.D., the Company?s Chairman, to the role of Executive Chairman, effective immediately.